男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

表皮生長因子受體(EGFR)重組抗體

Recombinant Antibody to Epidermal Growth Factor Receptor (EGFR)

ErbB-1; ErbB1; ER1; ERB-B1; MENA; HER1; Erythroblastic Leukemia Viral(v-Erb-B)oncogene Homolog,Avian; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1

  • 表皮生長因子受體(EGFR)重組抗體產(chǎn)品包裝(模擬)
  • 表皮生長因子受體(EGFR)重組抗體產(chǎn)品包裝(模擬)
  • 表皮生長因子受體(EGFR)重組抗體Human Hela cell line was?stained?with?5-10μg/ml?mouse Anti-human EGFR Recombinant Antibodies (Catalog # RAA757Hu21, red histogram)?or?Isotype?control?antibody?(Catalog # IS067-Mu03, green histogram),?followed?by?1μg/ml?FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog # SAA544Mu18).
  • 表皮生長因子受體(EGFR)重組抗體Human peripheral blood lymphocytes were stained with 0.2μg/ml mouse Anti-human EGFR Recombinant Antibody (Catalog RAA757Hu21, red histogram) or Isotype control antibody (Catalog IS067-Mu03, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對EGFR的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別EGFR。

用法

Western blotting: 0.2-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Flow cytometry:10μg/ml;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號適用物種：Homo sapiens (Human，人)應(yīng)用(僅供研究使用，不用于臨床診斷！)
APA757Hu01表皮生長因子受體(EGFR)活性蛋白Cell?culture;?Activity?Assays.
APA757Hu02表皮生長因子受體(EGFR)活性蛋白Cell?culture;?Activity?Assays.
APA757Hu62表皮生長因子受體(EGFR)活性蛋白Cell?culture;?Activity?Assays.
RPA757Hu01表皮生長因子受體(EGFR)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APA757Hu61表皮生長因子受體(EGFR)活性蛋白Cell?culture;?Activity?Assays.
EPA757Hu62表皮生長因子受體(EGFR)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA757Hu02表皮生長因子受體(EGFR)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
EPA757Hu61表皮生長因子受體(EGFR)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA757Hu06表皮生長因子受體(EGFR)多克隆抗體WB; IHC; ICC; IP.
PAA757Hu02表皮生長因子受體(EGFR)多克隆抗體WB; IHC; ICC; IP.
PAA757Hu01表皮生長因子受體(EGFR)多克隆抗體WB; IHC; ICC; IP.
FAA757Hu51抗表皮生長因子受體(EGFR)多克隆抗體(別藻藍(lán)蛋白標(biāo)記)FCM
MAA757Hu27表皮生長因子受體(EGFR)單克隆抗體WB; IHC; ICC; IP.
MAA757Hu29表皮生長因子受體(EGFR)單克隆抗體WB; IHC; ICC; IP.
RAA757Hu21表皮生長因子受體(EGFR)重組抗體WB; IF; ICC; IHC; IP; FCM.
MAA757Hu21表皮生長因子受體(EGFR)單克隆抗體WB; IHC; ICC; IP.
MAA757Hu23表皮生長因子受體(EGFR)單克隆抗體WB; IHC; ICC; IP.
MAA757Hu24表皮生長因子受體(EGFR)單克隆抗體WB; IHC; ICC; IP.
MAA757Hu25表皮生長因子受體(EGFR)單克隆抗體WB; IHC; ICC; IP.
MAA757Hu22表皮生長因子受體(EGFR)單克隆抗體WB; IHC
SEA757Hu表皮生長因子受體(EGFR)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
HEA757Hu表皮生長因子受體(EGFR)檢測試劑盒(酶聯(lián)免疫吸附試驗法,高敏型)Enzyme-linked immunosorbent assay for Antigen Detection.
AEA757Hu抗表皮生長因子受體抗體(Anti-EGFR)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antibody Detection.
LMA757Hu表皮生長因子受體(EGFR)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志參考文獻(xiàn)
Thoracic CancerNimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer[Wiley: source]
J Cent Nerv Syst Dis.?Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism …[Pubmed:25249767]
Mol Cancer TherGC1118, an anti-EGFR antibody with a distinct binding epitope and superior inhibitory activity against high-affinity EGFR ligands[PubMed: 26586721]
Cell Death Dis.?LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway[Pubmed:26938303]
analytica chimica acta Microfluidic immunosensor based on mesoporous silica platform and CMK-3/poly-acrylamide-co-methacrylate of dihydrolipoic acid modified gold electrode for cancer biomarker detection.[pubmed:28335979]
TalantaEGFR detection in extracellular vesicles of breast cancer patients through immunosensor based on silica-chitosan nanoplatform[Doi: 10.1016/j.talanta.2018.10.016]
Bioorganic ChemistryDesign, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers[Pubmed: 30665034]
Journal of?enzyme?inhibition and medicinal chemistryNovel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile[Pubmed: 30919701]
Bioorganic ChemistryDesign and synthesis of new benzoxazole/benzothiazole-phthalimide hybrids as antitumor-apoptotic agents[]
Bioorganic ChemistrySynthesis and anticancer activity of bis-benzo [d][1, 3] dioxol-5-yl thiourea derivatives with molecular docking study[Pubmed: 31288134]
Oxidative Medicine and Cellular LongevityEvaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters?…[Pubmed: 31737175]
NeoplasiaPatient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine[Pubmed: 33212364]
Association between Serum Epidermal Growth Factor Receptor and Cyclooxygenase-2 Levels in Patients with Non-small Cell Carcinoma of Lung[]
Synthesis, EGFR-TK inhibition and anticancer activity of new quinoxaline derivatives[]
IMMUNOLOGIC RESEARCHHumoral immune response to epidermal growth factor receptor in lung cancer[33495907]
European Journal of Medicinal ChemistryPyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure¨Cactivity relationship and biological activity as potential antitumor and anticonvulsant agents[33545637]
Journal of Molecular StructureDesign, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors[]
ACS Appl Mater InterfacesEmitter–Quencher Pair of Single Atomic Co Sites and Monolayer Titanium Carbide MXenes for Luminol Chemiluminescent Reactions[34914377]
Bioorganic ChemistryDiscovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies[Pubmed:35219045]